Skip to main content
ConductScienceScienceDex

Ling Qi

NIH Rank #3590
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9335858Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Physiology

NIH Funding · FY2025

Linked Award Amount
$2.9M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#3,590
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ling Qi. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Ling Qi as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG089640-02R01
    ERAD-STING Crosstalk in Microglia: Unraveling the Pathogenesis of Alzheimer's Disease
    University of Virginia
    $800.2K
    award amount
  • 5R01DK120330-07R01
    Novel role of hepatic SEL1L-HRD1 ERAD in bile acid metabolism
    University of Virginia
    $700.1K
    award amount
  • 1R01NS138119-01A1R01
    Mechanisms Underlying the Pathogenesis of SEL1L-HRD1 ERAD Disease Variants
    University of Virginia
    $654.8K
    award amount
  • 5R01DK137794-02R01
    A central role of SEL1L-HRD1 ERAD in LPL maturation in adipocytes
    University of Virginia
    $389.2K
    award amount
  • 5R01DK132786-03R01
    Mechanisms of ER-Protein Quality Control in Podocytes
    University of Virginia
    $367.3K
    award amount

Award organization

Organizations that administered FY2025 awards listing Ling Qi as a PI.

FY2025 award administered by University of Virginia (VA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Virginia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2741
  6. 2024
    Entered Top 25% Nationally
    Ranked #2741
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder
  9. 2026
    $10M Cumulative Funding
  10. 2026
    Entered Top 10% Nationally
    Ranked #494
  11. 2026
    Entered Top 5% Nationally
    Ranked #494

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Ling Qi.

Deyu Fang
University of Virginia
3
shared awards
Billy Tsai
University of Michigan
2
shared awards
Peter Arvan
University of Michigan
2
shared awards
Shengyi Sun
University of Virginia
2
shared awards
Zhen Zhao
University of Virginia
2
shared awards
Zhen Zhao
University of Virginia
1
shared award

Explore further

Find collaborators for Ling Qi

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →